Evidence map›Paper›PMID 37495957›Full record

ArticleThe journal of headache and pain2023

Optogenetic cortical spreading depolarization induces headache-related behaviour and neuroinflammatory responses some prolonged in familial hemiplegic migraine type 1 mice.

Anisa Dehghani, Maarten Schenke, Sandra H van Heiningen, Hulya Karatas, Else A Tolner, Arn M J M van den Maagdenberg

Abstract read
In one paragraph

Article in The journal of headache and pain, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Hemiplegic migraine: genetics and pathophysiology.The Journal of clinical investigation · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anisa DehghaniDepartment of Human Genetics, Leiden University Medical Center, Leiden, RC, 2300, The Netherlands. adehghan@bidmc.harvard.edu.ORCID http://orcid.org/0000-0002-7117-4599
Maarten SchenkeDepartment of Human Genetics, Leiden University Medical Center, Leiden, RC, 2300, The Netherlands.
Sandra H van HeiningenDepartment of Human Genetics, Leiden University Medical Center, Leiden, RC, 2300, The Netherlands.
Hulya KaratasInstitute of Neurological Sciences and Psychiatry, Hacettepe University, Ankara, Turkey.ORCID http://orcid.org/0000-0003-4838-6320
Else A Tolner *Department of Human Genetics, Leiden University Medical Center, Leiden, RC, 2300, The Netherlands.ORCID http://orcid.org/0000-0002-6501-9971
Arn M J M van den Maagdenberg *Department of Human Genetics, Leiden University Medical Center, Leiden, RC, 2300, The Netherlands. A.M.J.M.van_den_Maagdenberg@lumc.nl.ORCID http://orcid.org/0000-0002-9310-5535

Funding

European Union "Euroheadpain" grant 602633
6 · The paper itself

Abstract

backgroundCortical spreading depolarization (CSD), the neurophysiological correlate of the migraine aura, can activate trigeminal pain pathways, but the neurobiological mechanisms and behavioural consequences remain unclear. Here we investigated effects of optogenetically-induced CSDs on headache-related behaviour and neuroinflammatory responses in transgenic mice carrying a familial hemiplegic migraine type 1 (FHM1) mutation.

methodsCSD events (3 in total) were evoked in a minimally invasive manner by optogenetic stimulation through the intact skull in freely behaving wildtype (WT) and FHM1 mutant mice. Related behaviours were analysed using mouse grimace scale (MGS) scoring, head grooming, and nest building behaviour. Neuroinflammatory changes were investigated by assessing HMGB1 release with immunohistochemistry and by pre-treating mice with a selective Pannexin-1 channel inhibitor.

resultsIn both WT and FHM1 mutant mice, CSDs induced headache-related behaviour, as evidenced by increased MGS scores and the occurrence of oculotemporal strokes, at 30 min. Mice of both genotypes also showed decreased nest building behaviour after CSD. Whereas in WT mice MGS scores had normalized at 24 h after CSD, in FHM1 mutant mice scores were normalized only at 48 h. Of note, oculotemporal stroke behaviour already normalized 5 h after CSD, whereas nest building behaviour remained impaired at 72 h; no genotype differences were observed for either readout. Nuclear HMGB1 release in the cortex of FHM1 mutant mice, at 30 min after CSD, was increased bilaterally in both WT and FHM1 mutant mice, albeit that contralateral release was more pronounced in the mutant mice. Only in FHM1 mutant mice, contralateral release remained higher at 24 h after CSD, but at 48 h had returned to abnormal, elevated, baseline values, when compared to WT mice. Blocking Panx1 channels by TAT-Panx

conclusionsCSDs, induced in a minimally invasive manner by optogenetics, investigated in freely behaving mice, cause various migraine relevant behavioural and neuroinflammatory phenotypes that are more pronounced and longer-lasting in FHM1 mutant compared to WT mice. Prevention of CSD-related neuroinflammatory changes may have therapeutic potential in the treatment of migraine.

Indexed as

Cortical Spreading DepressionHMGB1 ProteinMigraine DisordersMigraine with AuraAnimalsConnexinsDisease Models, AnimalHeadacheInflammationMiceMice, TransgenicNerve Tissue ProteinsOptogeneticsConnexinsHMGB1 ProteinNerve Tissue ProteinsPanx1 protein, mouseCortical spreading depolarizationHeadache behaviourHMGB1Neuroinflammation; pannexin-1Optogenetics

Identifiers

PMID37495957
PMCPMC10373261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.